期刊文献+

高效液相色谱法测定泊沙康唑甲苯磺酸酯的对映异构体杂质

Determination of Enantiomeric Impurities of Posaconazole Toluene Sulfonate by High Performance Liquid Chromatography
下载PDF
导出
摘要 建立高效液相色谱法测定泊沙康唑关键起始物料泊沙康唑甲苯磺酸酯的对映异构体杂质,该方法使用表面共价键合有直链淀粉-三(3,5-二甲基苯基氨基甲酸酯)硅胶为填充剂的色谱柱(大赛璐CHIRALPAK IA,250 mm×4.6 mm,5μm),流动相为正己烷-无水乙醇(65:35),流速为1.0 mL/min,柱温为30℃,波长为225 nm,进样体积为10μL。对映异构体杂质的定量限为0.3μg/mL,在0.3~2.0μg/mL范围内的线性关系良好,平均回收率为98.5%,回收率RSD为0.8%。本方法专属性和准确度良好,灵敏度较高,可用于泊沙康唑甲苯磺酸酯的质量控制。 A high performance liquid chromatography(HPLC)method has been established for detecting the enantiomer impurity of posaconazole toluene sulfonate,a key starting material of posaconazole.A Daicel CHIRALPAK IA column(250 mm×4.6mm,5μm)was used,with the mobile phase of N-hexane-anhydrous ethanol(65:35),flow rate was 1.0 mL/min,the column temperature was set at 30℃,the wavelength of detector was 225 nm,and the injection volume was 10μL.The limit of quantitation of the enantiomer impurity was 0.3μg/mL,the method was linear from 0.3μg/mL to 2.0μg/mL,the accuracy was similar with a mean(RSD)ratio of 98.5%(0.8%).The method is simple,specific and sensitive,and can be used for the quality control of Posaconazole toluene sulfonate.
作者 张运海 伍鸣亮 曾海金 罗恒真 兰月香 ZHANG Yun-hai;WU Ming-liang;ZENG Hai-jin;LUO Heng-zhen;LAN Yue-xiang(Jiangxi Qingfeng Pharmaceutical Co.,Ltd.,Ganzhou,Jiangxi 341000,China)
出处 《浙江化工》 CAS 2021年第10期52-54,共3页 Zhejiang Chemical Industry
关键词 高效液相色谱法 泊沙康唑甲苯磺酸酯 关键起始物料 对映异构体杂质 质量控制 high performance liquid chromatography(HPLC) posaconazole toluene sulfonate key starting materials enantiomer impurity quality control
  • 相关文献

参考文献1

二级参考文献39

  • 1盛春泉,朱杰,张万年,宋云龙,张珉,季海涛,余建鑫,姚建忠,杨松,缪震元.新型三唑类化合物的合成及抗真菌活性[J].药学学报,2004,39(12):984-989. 被引量:10
  • 2刘想虎,冉红兵,肖学成.伊曲康唑羟丙基-β-环糊精包合物颗粒的制备与质量控制[J].医药导报,2005,24(4):325-327. 被引量:3
  • 3李科,张万年,杨济秋,吕加国,吴秋业.1-{2-[(取代苯基)甲氧基]-2-(取代苯基)乙基}-1H-三唑和苯并三唑类化合物的合成及抗真菌活性[J].药学学报,1995,30(3):191-204. 被引量:4
  • 4[2]Ji Haitao,Zhang Wannian,Zhou Youjun,et al.A three-Dimensional model of lanosterol 14α-demethylase of Candida albicans and its interaction with azole antifungal[J].J Med chem,2000,43(13):2 493-2 505.
  • 5[3]Rotstein D M,Kertesz D J.Stereoisomers of ketoconazole:Preparation and biological activity[J].J Med Chem,1992,35(15):2 818-2 825.
  • 6[4]Heeres J,Baekx L J J,Van Cutsem J,et al.Synthesis and antifungal properties of a series of novel triazole-3-ones[J].J Med Chem,1984,27(7):894-900.
  • 7[5]Heeres J,Baekxl J J.US,4 916 134[P].1990-04-10.
  • 8[8]Lieven Meerpoel,Leo J,Backx J,et al.Synthesis and in vitro and in vivo structure -activity relationships of novel antifungal triazole for dermatology[J].J Med Chem,2005,48(6):2 184-2 193.
  • 9[9]Law D,Moore C B,Denning D W.Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp[J].Antimicrob Agents Chemother,1997,41(10):2 310-2 311.
  • 10[10]Richardson K.Antifungal 1,3-bis-triazolyl-2-propanol derivative:US,4 404 216[P].1982-06-01.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部